Oxford covid-19 vaccine: AstraZeneca must explain spinal ailment to resume trial

The episode that triggered the halt is the second time a person taking part in the AstraZeneca study developed neurological symptoms, leading to a pause in research.The British drug maker’s vaccine has been considered one of the most likely contenders to reach the market in the near term

from mint - Science https://ift.tt/2FloW3u
https://ift.tt/eA8V8J